Use of platelet glycoprotein IIb/IIIa inhibitors and spontaneous pulmonary hemorrhage

The use of platelet glycoprotein (GP) IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention has resulted in an impressive reduction in adverse events. Pulmonary hemorrhage is a rare but potentially lethal complication of antithrombotic and antiplatelet therapy. We analyzed th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of invasive cardiology 2003-04, Vol.15 (4), p.186
Hauptverfasser:	Ali, Arshad, Hashem, Mustafa, Rosman, Howard S, Kazmouz, Ghassan, Gardin, Julius M, Schrieber, Theodore L
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antibodies, Monoclonal - adverse effects Female Hemorrhage - chemically induced Hemorrhage - epidemiology Humans Immunoglobulin Fab Fragments - adverse effects Incidence Lung Diseases - chemically induced Lung Diseases - epidemiology Male Michigan - epidemiology Middle Aged Peptides - adverse effects Peptides - antagonists & inhibitors Platelet Aggregation Inhibitors - adverse effects Platelet Glycoprotein GPIIb-IIIa Complex - adverse effects Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors Pulmonary Wedge Pressure - drug effects Treatment Failure Tyrosine - adverse effects Tyrosine - analogs & derivatives Tyrosine - antagonists & inhibitors Ventricular Pressure - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!